CIBC Private Wealth Group’s Pacific Biosciences PACB Stock Holding History

CIBC Private Wealth Group’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.95K	Buy	1,040 +181	+21%	+$348	﹤0.01%	2805
2025 Q3	$1.1K	Sell	859 -650	-43%	-$880	﹤0.01%	2805
2025 Q2	$1.87K	Hold	1,509	–	–	﹤0.01%	2651
2025 Q1	$1.81K	Hold	1,509	–	–	﹤0.01%	2707
2024 Q4	$3.17K	Sell	1,509 -1,000	-40%	-$1.95K	﹤0.01%	2603
2024 Q3	$4.26K	Buy	2,509 +775	+45%	+$1.27K	﹤0.01%	2633
2024 Q2	$2.32K	Buy	1,734 +250	+17%	+$505	﹤0.01%	2731
2024 Q1	$5.42K	Buy	+1,484	New	+$8.69K	﹤0.01%	2481

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC Private Wealth Group's PACB Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Pacific Biosciences (PACB) stake by 21% in Q4 2025, buying an estimated $348 and bringing the position to 1,040 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #2805.

CIBC Private Wealth Group first reported a position in PACB in Q1 2024 and has held it in 8 quarters since. The position peaked at $5.42K in Q1 2024. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

CIBC Private Wealth Group held 1,040 shares of Pacific Biosciences worth $1.95K as of Q4 2025.
CIBC Private Wealth Group bought 181 Pacific Biosciences shares in Q4 2025, an estimated $348.
Pacific Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2805 holding.
CIBC Private Wealth Group first reported a position in Pacific Biosciences in Q1 2024 and has held it in 8 quarters since.
CIBC Private Wealth Group's Pacific Biosciences position peaked at $5.42K in Q1 2024.
215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.